RNA immunoprecipitation (RIP) and luciferase reporter assays indicated that FGF14-AS2 acted as a ceRNA of miR-370-3p, allowing FGF14 upregulation and subsequently suppressing breast cancer metastasis. The gene discussed is FGF14; the disease is breast carcinoma.